Craig-Hallum initiates Prenetics Global at Buy, $40 target
Craig-Hallum initiated coverage of Prenetics Global with a Buy rating and a $40.00 per-share price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.